Panjon Limited (BOM:526345)
24.54
+2.14 (9.55%)
At close: Sep 7, 2026
Panjon Revenue
Panjon had revenue of 80.74M INR in the quarter ending June 30, 2026, with 25.84% growth. This brings the company's revenue in the last twelve months to 492.78M, up 41.68% year-over-year. In the fiscal year ending March 31, 2026, Panjon had annual revenue of 476.21M with 56.35% growth.
Revenue (ttm)
492.78M
Revenue Growth
+41.68%
P/S Ratio
0.78
Revenue / Employee
12.32M
Employees
40
Market Cap
384.49M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 476.21M | 171.63M | 56.35% |
| Mar 31, 2025 | 304.58M | 179.06M | 142.65% |
| Mar 31, 2024 | 125.52M | 64.61M | 106.07% |
| Mar 31, 2023 | 60.91M | -23.41M | -27.76% |
| Mar 31, 2022 | 84.32M | -61.07M | -42.00% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Mangalam Drugs & Organics | 2.32B |
| Rajnish Wellness | 1.68B |
| JFL Life Sciences | 1.31B |
| ANG Lifesciences India | 862.13M |
| Sandu Pharmaceuticals | 696.24M |
| Gujarat Terce Laboratories | 456.22M |
| Cian Healthcare | 294.69M |